The Study of Potential Antiviral Compounds from Indonesian Medicinal Plants as Anti-COVID-19 with Molecular Docking Approach by Rizma, Baiq Ressa Puspita et al.
Journal of Molecular Docking http://journal.umpalangkaraya.ac.id/index.php/jmd/article/view/2307  
Vol 1 Issue 1 June 2021  DOI: https://doi.org/10.33084/jmd.v1i1.2307 




Corona Virus Disease 2019 (COVID-19) is a disease 
caused by the outbreak of SARS-CoV-2 infection, a 
new coronavirus strain1. Food and Drug 
Administration of America (US FDA) stated that there 
is still no specific drug to inhibit the virus until this 
paper was written. Only broad-spectrum antiviral 
such as remdesivir are used to treat the infection2. 
Remdesivir is a prodrug and nucleoside analog, as a 
prodrug remdesivir has two active metabolites such as 
remdesivir nucleoside (GS-441524) and remdesivir 
triphosphate (GS-443902)3,4. 
The rapid transmission of COVID-19 from human to 
human forces researchers to find a potent drug, 
including using natural sources as an alternative5. 
However, natural drug development has its limitation, 
including it is time-consuming. This limitation could 
be addressed by using the molecular docking 
approach6,7. Molecular docking is one of the in silico 
approaches used to design or select compounds that 
can be used as an inhibitor or an activator of a target 
protein, and it also assesses the mechanism of action in 
the molecular state8. 
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Corona Virus Disease 2019 (COVID-19) is a new strain of coronavirus 
called SARS-CoV-2, which was identified in Wuhan, China, in 
December 2019. The rapid transmission of COVID-19 from human to 
human forced researchers to find a potent drug by setting aside the 
time-consuming traditional method in drug development. The 
molecular docking approach is one a reliable method to screening 
compound from chemical drug or by finding a compound from 
Indonesian herbal plants. The present study aimed to assess the 
potency of compounds from five medicinal plants as potential 
inhibitors of PLpro and 3CLpro from SARS-CoV-2 using molecular 
study. The molecular docking was performed using Protein-Ligand 
Ant System (PLANTS) to analyze the potential compounds by the 
docking score. Remdesivir triphosphate was used as a standard for the 
comparison of the test compounds. The docking score obtained from 
the docking of PLpro with native ligand, remdesivir triphosphate, 
curcumin, demethoxycurcumin, bisdemethoxycurcumin, luteolin, 
apigenin, quercetin, kaempferol, formononetin-7-O-glucuronide, 
andrographolide, and neoandrographolide were -111.441, -103.827, -
103.609, -102.363, -100.27, -79.6655, -78.6901, -80.9337, -79.4686, -
82.1124, -79.1789, and -97.2452, respectively. Meanwhile, docking 
score with 3CLpro for the same ligand were -64.0074, -86.1811, -81.428, 
-87.1625, -78.2899, -73.4345, -70.3368, -71.5539, -68.4321, -72.0154, -
75.9777, and -93.7746. The docking score data suggest that curcumin 
was the most potential as a PLpro inhibitor, while neoandrographolide 
was the best as a 3CLpro inhibitor. 
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As mentioned by the Indonesian Food and Drug 
Administration (BPOM Indonesia), several medicinal 
plants from Indonesia with antiviral activity can be 
used to treat COVID-19 patients, such as turmeric 
(Curcuma longa), curcuma (Curcuma xanthorrhiza), gale 
of the wind/meniran (Phyllanthus niruri), green 
chiretta/sambiloto (Andrographis paniculata), and 
guava (Psidium guajava)9. Some research has been done 
to prove the plants have potential secondary 
metabolite as an antiviral to support this statement. 
Curcumin, demethoxycurcumin, and 
bisdemethoxycurcumin in C. longa or C. xanthorrhiza 
have been shown to have an activity to inhibit 3C-like 
protease (3CLpro) and spike protein of SARS-CoV-2 in 
the in silico study. At the same time, another study also 
reported that curcumin affect 3CLpro of SARS-CoV-2 in 
the in vitro research10,11. Based on in vitro study, 
quercetin in P. guajava was shown to inhibit SARS-
CoV-2 papain-like protease (PLpro) with an IC50 of 8.6 
µM12. Luteolin, apigenin, quercetin, and kaempferol in 
P. guajava also shown potency to inhibit 3CLpro of 
SARS-CoV-2 based on in silico study13. Based on 
another in silico study with AutoDock Vina, quercitrin 
in P. niruri, as well as andrographolide and 
neoandrographolide from A. paniculata, show the best 
potential as a 3CLpro SARS-CoV-2 inhibitor based on 
free energy acquisition14. 
In the life cycle of SARS-Cov-2, two non-structural 
proteins have a crucial role. First, 3CLpro plays a role in 
replicating polypeptides into functional proteins to 
multiply viruses15. The 3CLpro plays a role in 
synthesizing replicas through proteolysis 
mechanisms, and viruses will use these replicas to 
construct structural proteins to multiply themself16. 
Meanwhile, PLpro serves as an essential virulence 
factor for the virus. The PLpro works by untying ISG15 
from IRF3, thus inhibiting Interferon (I and III) 
formation, which serves to signal the immune 
system17. This protein has the potential to be used as a 
target for treatment; in addition to genetic similarities 
between SARS-CoV (96%) and SARS-CoV-2, 3CLpro 
and PLpro also has not undergone mutations such as 
D614G in viral spike proteins18. Based on this 
background, this study aims to assess the potency of 
compounds from five medicinal plants from 
Indonesia, as mentioned before, as a potential inhibitor 
of PLpro and 3CLpro from SARS-CoV-2, using a 
molecular docking approach. 
 
METHOD 
Hardware and Software 
The hardware used was Asus notebook with Intel® 
Core™ RAM 4.00 GB, Operation System Windows 10, 
64-bit operating system. The software used was 
YASARA View 19.12.14 from YASARA Bioscience 
(http://www.yasara.org/), MarvinSketch 5.2.6 from 
ChemAxon 
(https://chemaxon.com/products/marvin), and 









Ligands in this research were divided into two groups: 
test and standard ligand. The test ligands were 
curcumin (PubChem ID 969516), 
bisdemethoxycurcumin (5315472), 
demethoxycurcumin (5469424), apigenin (5280443), 
luteolin (5280445), kaempferol (5280863), quercetin 
(5280343), formononetin-7-O-glucuronide (71316927), 
andrographolide (5318517), and neoandrographolide 
(9848024). The standard ligands were remdesivir 
triphosphate (56832906). The two-dimension structure 
of each ligand was obtained from the PubChem 
database (https://pubchem.ncbi.nlm.nih.gov/), then 
it was optimized into three-dimension using 
MarvinSketch to obtain the best conformation with the 
lowest energy. 
Receptors 
The receptors used in this study were SARS-CoV-2 
PLpro (PDB ID 3E9S) and 3CLpro (5R7Y)19, which 
downloaded from Protein Data Bank 
(https://www.rcsb.org). 
Docking protocol 
Overall, the docking protocol used in this study was 
based on the docking protocol used by Purnomo et al20. 
Preparation of target protein and native ligand 
The target protein and native ligand preparation were 
carried out using YASARA View. The protein was 
obtained by deleting its native ligand in the PDB file 
(Figure 1). In contrast, the native ligand was obtained 
by deleting the protein from the PDB file (Figure 2). In 
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this step, the protein and native ligand file were 












Figure 2. Three-dimension structure of (A) PLpro and (B) 3CLpro 
native ligand. 
Docking protocol validation 
Docking protocol validation aims to obtain a root 
median square deviation (RMSD) value. The RMSD 
value was asses using YASARA View by re-docking 
the native ligand to its protein. Docking protocols 
stated as a valid protocol if the RMSD value <2 Å21. 
Test ligand docking 
Docking was done using PLANTS by typing the 
commands in cmd.exe. The optimized test ligand was 
docked to the active site of both PLpro and 3CLpro. 
PLANTS will read the command that has been set 
before to obtain the best docking score of each test 
ligand. The final result of the docking score would be 
compared with the best score of the native ligand. 
Assessment 
The assessment was performed using a descriptive 
approach. The results from the docking process were 
the docking score of each interaction between the test 
ligand and target protein. The docking score indicates 
affinity between the ligand and target protein. The 
docking score was described as a negative value, 
meaning the test ligand had a good affinity and 
potential as the inhibitor of the target protein22. The test 
ligand was stated to had potential as the target protein 
inhibitor if the docking score was more negative than 
the docking score of remdesivir triphosphate. 
 
RESULTS AND DISCUSSION 
Docking protocol validation 
The RMSD value of PLpro and its native ligand 5-
amino-2-methyl-N-[(1R)-1-naphthalen-1-
ylethyl]benzamide was 0.5707 Å, and the RMSD value 
of 3CLpro with N-(2-phenylethyl)methanesulfonamide 
was 1.5525 Å (Figure 3). Based on the RMSD value, the 
docking protocol was valid because the value was less 
than 2 Å. 
Curcuma longa and Curcuma xanthorrhiza 
The docking score between curcumin, 
demethoxycurcumin, and bisdemethoxycurcumin 
with both PLpro and 3CLpro was shown in Figure 4. The 
interaction shows that curcumin had the best potency 
as a PLpro inhibitor because the docking score (-
103.609) was almost the same as remdesivir 
triphosphate (-103.827). Another in silico research 
using AutoDock Vina claimed curcumin acted best as 
PLpro inhibitor among four other targets like 
angiotensin-converting enzyme 2 (ACE2), 
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transmembrane serine protease 2 (TMPRSS2), RNA-
dependent RNA polymerase (RdRp), and 3CLpro, with 
the free binding energy (ΔG) of -8.45 kcal/mol, which 
was less than those ACE2 (-7.99 kcal/mol), TMPRSS2 






Figure 3. RMSD value of (A) PLpro (0.5707 Å) and (B) 3CLpro 
(1.5525 Å). 
 
Interaction with 3CLpro shows demethoxycurcumin 
was the most potent inhibitor of 3CLpro. The docking 
score of demethoxycurcumin (-87.1625) was less than 
remdesivir triphosphates (-86.1811). Sharma et al.24 
reported that demethoxycurcumin was one of the best 
inhibitors of 3CLpro with ΔG of -7.02 kcal/mol. This 
result was based on in silico study using AutoDock 4 to 
assess some medicinal plants metabolites as 3CLpro 
inhibitor. 
Curcuminoids in both plants have been shown to have 
antiviral activity, in which curcumin shows antiviral 
activity in HIV as a protease inhibitor in HIV-1 and 
HIV-2 based on in vitro and in vivo studies25. Other 
studies suggest that curcumin shows the activity as a 
SARS-CoV-2 3CLpro and spike protein inhibitor based 
on molecular docking study10,11. Curcumin also 
reported inhibiting 3CLpro in SARS-CoV with an IC50 
of 3.3 to 10 µM26. 
Psidium guajava 
The docking score between luteolin, apigenin, 
quercetin, and kaempferol with both PLpro and 3CLpro 
was shown in Figure 5. It turns out that the ligands 
were not potent enough as a PLpro inhibitor. However, 
among the four ligands, quercetin had the lowest 
docking score of -80.286. Interaction with 3CLpro shows 
that luteolin (-73.4345), apigenin (-70.3368), quercetin (-
71.5539), and kaempferol (-68.4321) had potency as 
3CLpro inhibitor, although the docking score was still 
higher than remdesivir triphosphate (-86.1811). 
Previous in silico research has shown that based on the 
free binding energy data, apigenin, luteolin, and 
quercetin had more potential as 3CLpro inhibitors (-7.4; 
-7.12; and -6.83 kcal/mol, respectively) than as PLpro 
inhibitor (-6.6; -6.9; and -6.6 kcal/mol)23. 
Phyllanthus niruri 
The docking score of formononetin-7-O-glucuronide 
with PLpro and 3CLpro was presented in Figure 6. The 
docking score data shows that formononetin-7-O-
glucuronide might not have potency as a PLpro 
inhibitor but had potency as an inhibitor of 3CLpro 
because the docking score (-72.0154) was less than 
native ligand (-64.0074) but higher than remdesivir 
triphosphate (-86.1811). Docking between 
formononetin-7-O-glucuronide and the receptor for 
SARS-CoV-2 has not been previously reported, 
whereas another similar study using a metabolite of P. 
niruri chose nirurin as the test ligand27. 
Andrographis paniculata 
Andrographis paniculata was an Indonesian plant with 
the main metabolite in lactone terpenoids such as 
andrographolide and neoandrographolide28. The 
docking score of andrographolide and 
neoandrographolide with PLpro and 3CLpro was shown 
in Figure 7. Based on the results, both 
andrographolide (-79.1989) and neoandrographolide 
(-97.2452) had no potency as PLpro inhibitors. On the 
contrary, the interaction between neoandrographolide 
with 3CLpro shows the docking score (-93.7746) less 
than remdesivir triphosphate (-86.1811) and could act 
as the most potent ligand for 3CLpro inhibitor. 
Murugan et al.14 reported that in the in silico research 
using AutoDock Vina, neoandrographolide had ΔG as 
3CLpro (-31.4 kcal/mol), PLpro (-28.5 kcal/mol), RdRp (-
17.1 kcal/mol), and spike protein (-23.9 kcal/mol) 
inhibitors, in which they were best for 3CLpro inhibitor. 
In addition, andrographolide was the main antiviral 
compound that was often found in A. paniculata29. This 
compound could inhibit the dengue virus in HeLa 
(EC50 22.739 µM) and HepG2 (EC50 21.304 µM) cells30. 
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Figure 4. Docking score of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. 
 
 
Figure 5. Docking score of luteolin, apigenin, quercetin and kaempferol. 
 
 
Figure 6. Docking score of formononetin-7-O-glucuronide. 
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Luteolin Apigenin Quercetin Kaempferol Native Ligand Remdesivir tp
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Figure 7. Docking score of andrographolide and neoandrographolide. 
 
Based on the docking score of test ligands with PLpro, 
curcumin was the most potent inhibitor of PLpro with 
the lowest docking score of -103.609, while apigenin 
was the ligand with the highest docking score, as 
shown in Table I. This result indicates that curcumin 
had a good affinity when the interaction occurred 
between the ligand and PLpro. Based on the docking 
score, neoandrographolide was the ligand with the 
lowest docking score of -93.7746, while kaempferol 
was the highest with -68.4321. The docking score of 
neoandrographolide indicated a good affinity with 
3CLpro and potency to acted as the most potent ligand 
to inhibit 3CLpro. Curcumin and neoandrographolide 
were stated as the most potent candidate for PLpro and 
3CLpro inhibitors, respectively.  




Native ligand -111.441 -64.0074 
Remdesivir triphosphate -103.827 -86.1811 
Apigenin -78.6901 -70.3368 
Andrographolide -79.1789 -75.9777 
Kaempferol -79.4686 -68.4321 
Luteolin -79.6655 -73.4345 
Quercetin -80.9337 -71.5539 
Formononetin-7-O-glucuronide  -82.1124 -72.0154 
Neoandrographolide -97.2452 -93.7746 
Bisdemethoxycurcumin -100.271 -78.2899 
Demethoxycurcumin -102.363 -87.1625 
Curcumin -103.609 -81.428 
 
The prediction from this research could be used to 
develop an anti-COVID-19 drug from herbal 
compounds such as combination with extract or 
isolate that contains curcumin and 
neoandrographolide as the main compounds. 
Moreover, combining these two compounds could 
enhance the inhibitor effect in PLpro or 3CLpro of SARS-
CoV-2. However, further in vitro and in vivo research 
was required to confirm this finding. 
 
CONCLUSION 
Based on the docking score, it can be concluded that 
curcumin has the most potential as a PLpro inhibitor, 
while neoandrogapholide has the most potential as a 
3CLpro inhibitor. 
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